“The efficacy of administering elbasvir/grazoprevir as hepatitis C therapy in hemodialysis patients with comorbid of hypertension and diabetes mellitus” (2023) Jurnal Penyakit Dalam Udayana, 7(2), pp. 35–38. doi:10.36216/jpd.v7i2.228.